Spotlight on lamotrigine in bipolar disorder

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Bipolar I disorder is a significant mental health condition characterized by mood episodes.
• Lamotrigine, a phenyltriazine derivative, is an established anticonvulsant.
• Its mechanism in bipolar disorder may involve stabilizing neuronal membranes by inhibiting ion channels.

Purpose of the Study:

• To evaluate the efficacy of lamotrigine as a maintenance therapy for bipolar I disorder.
• To compare lamotrigine's effectiveness against placebo in preventing mood episodes.
• To assess lamotrigine's efficacy in treating acute bipolar depression versus acute mania.

Main Methods:

• Two large, randomized, double-blind, 18-month trials compared lamotrigine monotherapy to placebo.
• Studies assessed time to intervention for any mood episode (mania, hypomania, depression, mixed).
• Short-term studies evaluated lamotrigine for treatment-refractory bipolar disorder and bipolar depression.

Main Results:

• Lamotrigine significantly delayed intervention for any mood episode compared to placebo.
• It was significantly superior to placebo in prolonging time to intervention for depression.
• Lamotrigine showed limited efficacy in delaying manic/hypomanic episodes and no efficacy in acute mania treatment.

Conclusions:

• Lamotrigine is effective for maintenance therapy in bipolar I disorder, delaying mood episodes.
• It shows efficacy in treating acute bipolar depression but not acute mania.
• Lamotrigine is generally well-tolerated, does not cause weight gain, and typically avoids serum level monitoring.